Physician profile

Norman Neslin

Gastroenterology (Internal Medicine) · Utica, NY

NPI 1568444172

$1,763.23

in general payments reported to CMS, 2019-2025

17 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $474.25 2019-2021
Pfizer INC. $347.22 2019-2020
Janssen Biotech, INC. $223.99 2019-2022
Ucb, INC. $219.80 2019-2020
Takeda Pharmaceuticals U.S.A., INC. $162.10 2019-2021
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $72.32 2019
Gilead Sciences, INC. $52.40 2019
Janssen Scientific Affairs, LLC $33.85 2019
Qol Medical, LLC $32.21 2019
Shire North American Group INC $30.46 2019
Alexion Pharmaceuticals, INC. $22.50 2019
Merck Sharp & Dohme LLC $18.75 2019
Endo Pharmaceuticals INC. $18.00 2019
Medtronic, INC. $17.91 2021
Conmed Corporation $13.28 2021
Show all 17 companies
CompanyGeneral paymentsYearsTop products
Hospira, INC. $12.50 2019
Janssen Pharmaceuticals, INC $11.69 2020

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Norman Neslin

$1,763.23

in general payments reported 2019-2025

Years
2019-2022
Top company
Abbvie INC.

https://glasscript.com/doctor/549913/norman-neslin

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.